Scale Biosciences, founded in 2020, is a pioneering entity in the Analytics and Biotechnology sectors, based in the United States. The company’s slogan, “Boldly go where your single cell research takes you,” encapsulates its mission to enhance single-cell research.
Specializing in providing innovative platforms that emphasize accessibility, flexibility, and scalability, Scale Biosciences enables researchers to conduct complex biological experiments efficiently. The company’s ability to analyze millions of cells and multiplex hundreds of samples grants scientists the capacity to generate comprehensive datasets, driving new insights into intricate biological systems.
Their most recent financial milestone was a successful $30.00M acquisition investment on 01 August 2025, led by 10X Genomics. This partnership signals strong market confidence in Scale Biosciences’ ability to revolutionize the biotechnology landscape.